Remdesivir for COVID‐19 pneumonia in patients with severe chronic kidney disease: A Case series and review of the literature - Wiley

Our report suggests that Remdesivir is well tolerated and potentially safe among hospitalized patients with severe COVID-19 infection with the background of advanced kidney diseases where benefits ou...

1 INTRODUCTION In late 2019, SARS-CoV-2 infection leading to COVID-19 disease emerged from Wuhan province in China to cause an unprecedented pandemic with global consequences. From foremost reports,… [+15464 chars]

full article...